Skip to main content

Animations

MJFF Publications

1991 - 2000 of 8404 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • Summary Details
    OPEN
    Title: Influence of Age on Magnitude and Timing of Vasodepression and Cardioinhibition in Tilt-Induced Vasovagal Syncope
    Journal Name: JACC: Clinical Electrophysiology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.jacep.2022.05.009
    Citation Count: 25
  • Summary Details
    OPEN
    Title: Intermuscular coherence as a biomarker of subthalamic nucleus deep brain stimulation efficacy in Parkinson’s disease
    Journal Name: Clinical Neurophysiology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.clinph.2022.07.489
    Citation Count: 1
  • Summary Details
    RESTRICTED
    Title: Recent advances in establishing fluid biomarkers for the diagnosis and differentiation of alpha-synucleinopathies – a mini review
    Journal Name: Clinical Autonomic Research
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s10286-022-00882-1
    Citation Count: 5
  • Summary Details
    RESTRICTED
    Title: Table for One
    Journal Name: Brain & Life
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1097/01.nnn.0000856280.92010.9b
    Best OA location URL:
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Association of Cerebrospinal Fluid Neurofilament Heavy Protein Levels With Clinical Progression in Patients With Parkinson Disease
    Journal Name: JAMA Network Open
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1001/jamanetworkopen.2022.23821
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Disruption of Dopamine Receptor 1 Localization to Primary Cilia Impairs Signaling in Striatal Neurons
    Journal Name: The Journal of Neuroscience
    Publisher: Society for Neuroscience
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1523/jneurosci.0497-22.2022
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Identification of risk genes for Alzheimer’s disease by gene embedding
    Journal Name: Cell Genomics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.xgen.2022.100162
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Shared mechanisms across the major psychiatric and neurodegenerative diseases
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-022-31873-5
    Citation Count: 119
  • Summary Details
    OPEN
    Title: Chemical Replacement of Noggin with Dorsomorphin Homolog 1 for Cost-Effective Direct Neuronal Conversion
    Journal Name: Cellular Reprogramming
    Publisher: Mary Ann Liebert Inc
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1089/cell.2021.0200
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Elevated Plasma Phosphorylated Tau 181 in Amyotrophic Lateral Sclerosis
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.26462
    Citation Count: 28
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.